| |
|
|
|
Xtalks, Online
2024-09-17
Chimeric antigen receptor (CAR)-T cell therapies have become an important treatment modality for cancer but there remains a significant opportunity to enhance CAR-T therapies and leverage these therapeutics to address unmet clinical needs.
As these therapies evolve, their application is expanding beyond hematologic malignancies and advancements in science and technology are improving their efficacy, safety and durability of response. Next-generation CAR-T therapies have the potential to further transform the cancer treatment landscape by positively impacting outcomes, reducing toxicities and logistical complexity and enhancing patient accessibility and convenience.
In this webinar, the expert speakers will explore the latest innovations in CAR-T therapy and discuss key operational considerations aimed at improving the efficiency of clinical trials and enriching the experience of study participation for oncology patients.
Register for this webinar today to gain insights into how next-generation CAR-T therapies are transforming cancer care, focusing on enhancing patient outcomes and streamlining oncology clinical trials.
Keywords: Drug Development, Clinical Research, CRO, Oncology, CAR-T, Clinical Data, Regulatory, Oncology Trials, Oncology Clinical Trials, Therapeutic Areas, CAR T-Cell Therapy, Cell & Gene Therapies
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Ashley Herrick, PhD, VP, Oncology Strategy, Premier Research
Meera Belur, Executive Director, Program Strategy, Oncology, Premier Research
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-09-17
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|